Here’s how we can support your weight loss journey:

1. Online consultations: We connect patients with healthcare professionals through virtual consultations, discussing weight loss goals, medical history, and other factors without needing to visit a physical clinic.
2. Personalized plans: Based on the consultations, MED MAN MD healthcare professionals can develop personalized weight loss plans tailored to the specific needs, preferences, and lifestyle of each patient.
3. Prescription medications: If appropriate, our medical providers can prescribe weight loss medications, such semaglutide online or other GLP-1 receptor agonists. Cost of medications is included in the program.
4. Ongoing support: MED MAN MD provides ongoing support and follow-up consultations with healthcare professionals to monitor progress, address any concerns, and make adjustments to the weight loss plan as needed.

MED MAN MD prescribes FDA-approved Wegovy®, working with licensed pharmacies to ensure safe and effective treatment. Wegovy® is manufactured under strict FDA guidelines and dispensed through state-licensed pharmacies that meet all federal and state regulations, including administrative requirements and quality standards. Join thousands on a medically guided journey to sustainable weight loss with trusted, FDA-approved Wegovy®.

The same FDA-approved medication trusted for long-term weight management.

MedMan Compounded Semaglutide & Tirzepatide Treatment Guide
Advanced GLP-1 Therapies for Weight Management & Metabolic Support

Please Note: Compounded medications, including compounded semaglutide and tirzepatide, may be prescribed by licensed physicians but are not FDA-approved. FDA-approved versions of semaglutide are available and may be considered as alternatives. Compounded medications are not reviewed by the FDA for safety, effectiveness, or manufacturing quality.

⚠️ Important Safety Warnings
Seek immediate in-person medical care or contact your doctor if you experience any of the following:

Severe nausea, vomiting, or dehydration
Stay well-hydrated to avoid complications, especially if experiencing gastrointestinal symptoms.

Kidney issues or kidney failure
Vomiting and diarrhea may worsen kidney problems in those with pre-existing conditions. Dehydration may require hemodialysis.

Signs of thyroid cancer (Thyroid C-Cell Tumor)
Look out for hoarseness, difficulty swallowing, neck swelling, or shortness of breath. (See Black Box Warning below.)

Pancreatitis
Severe abdominal or back pain that does not go away may indicate inflammation of the pancreas.

Gallbladder disease
Symptoms include upper abdominal pain, fever, yellowing of the eyes or skin, nausea/vomiting. Further evaluation may be required.

Hepatitis or liver issues
Includes jaundice or elevated liver enzymes.

Diabetic retinopathy
Vision changes in those with type 2 diabetes, especially those with prior eye complications.

Severe gastrointestinal disease
Avoid use if you have a history of serious gastrointestinal disorders.

Low blood sugar (hypoglycemia)
Rare with GLP-1s, but possible when combined with insulin or sulfonylureas. Symptoms: shakiness, dizziness, confusion, slurred speech, sweating, anxiety, or fainting.
Immediate Action: Consume 15–20g of sugar (e.g., juice, candy, soda).

Increased heart rate

Worsening depression, mood changes, or suicidal thoughts

Allergic reactions
Swelling of the face, lips, throat; rash, itching, trouble breathing, rapid heartbeat, or fainting.

⚠️ Never share your compounded semaglutide or tirzepatide with others.

💊 Drug & Supplement Interactions
Alcohol & Medication Interactions
Avoid alcohol. Compounded semaglutide may interact with both prescription and over-the-counter medications.

Gastrointestinal Effects on Oral Drugs
Delays gastric emptying and may affect absorption of oral medications.

Hormonal Medications
If taking thyroid or hormonal medications, consult your prescribing doctor to adjust timing.

Narrow Therapeutic Drugs (e.g., Warfarin)
Monitor drug levels closely under medical supervision.

🧬 BLACK BOX WARNING – Thyroid C-Cell Tumors
GLP-1 receptor agonists like semaglutide and tirzepatide are contraindicated in patients with:

Personal or family history of medullary thyroid carcinoma

Multiple endocrine neoplasia syndrome type 2 (MEN 2)

In animal studies, GLP-1 drugs have caused thyroid tumors. It is unknown if this risk applies to humans.
Contact your physician immediately if you experience:

Neck swelling or lumps

Hoarseness

Difficulty swallowing

Shortness of breath

👩‍⚕️ Precautionary Guidance
Consult your healthcare provider before beginning treatment. Share your full medical history.

Avoid use if pregnant, planning pregnancy, or breastfeeding.
Discontinue use at least 2 months prior to attempting conception.
These medications may cause fetal harm.

Use adequate contraception while on this therapy.

Notify your provider if you have any kidney, liver, pancreas, or thyroid concerns.

📞 What To Do in Case of Emergency
Call 911 or visit your nearest emergency room immediately for medical emergencies.

To report adverse events or reactions, contact the FDA at 1-800-FDA-1088 or submit a report at www.fda.gov/medwatch.

📌 Legal & Safety Disclaimers
This product is compounded in the United States and prescribed as part of a physician-guided program.
All compounded medications are custom-mixed by a licensed pharmacy but are not evaluated by the FDA.
Statements provided are not intended to diagnose, treat, cure, or prevent any disease.

🧬 MedMan Health | Feel Better. Live Stronger.
Your partner in modern health optimization.